• Profile
Close

Increased hemoglobin A 1c time in range reduces adverse health outcomes in older adults with diabetes

Diabetes Care Jun 18, 2021

Prentice JC, Mohr DC, Zhang L, et al. - Since short- and long-term glycemic variability are risk factors for diabetes complications, however, there are no validated A1C target ranges or measures of A1C stability in older adults, researchers performed a retrospective observational study to assess the correlation of a patient-specific A1C variability measure, A1C time in range (A1C TIR), on major adverse outcomes. Patients were ≥ 65 years old, had diabetes, and underwent at least four A1C tests over a 3-year period. Participants in the study were 402,043 veterans (mean [SD] age 76.9 [5.7] years, 98.8% male). A1C TIR had a graded relationship with mortality and cardiovascular disease (CVD) during an average of 5.5 years of follow-up. Maintaining A1C levels within individualized target ranges in older adults with diabetes is associated with a lower risk of mortality and CVD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay